Literature DB >> 2308957

Pahhph-5: a mouse mutant deficient in phenylalanine hydroxylase.

J D McDonald1, V C Bode, W F Dove, A Shedlovsky.   

Abstract

Mutant mice exhibiting heritable hyperphenylalaninemia have been isolated after ethylnitrosourea mutagenesis of the germ line. We describe one mutant pedigree in which phenylalanine hydroxylase activity is severely deficient in homozygotes and reduced in heterozygotes while other biochemical components of phenylalanine catabolism are normal. In homozygotes, injection of phenylalanine causes severe hyperphenylalaninemia and urinary excretion of phenylketones but not hypertyrosinemia. Severe chronic hyperphenylalaninemia can be produced when mutant homozygotes are given phenylalanine in their drinking water. Genetic mapping has localized the mutation to murine chromosome 10 at or near the Pah locus, the structural gene for phenylalanine hydroxylase. This mutant provides a useful genetic animal model affected in the same enzyme as in human phenylketonuria.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2308957      PMCID: PMC53605          DOI: 10.1073/pnas.87.5.1965

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Liver phenylalanine hydroxylase assay.

Authors:  V G Zannoni
Journal:  Biochem Med       Date:  1976-12

2.  Biochemical defect of the hph-1 mouse mutant is a deficiency in GTP-cyclohydrolase activity.

Authors:  J D McDonald; R G Cotton; I Jennings; F D Ledley; S L Woo; V C Bode
Journal:  J Neurochem       Date:  1988-02       Impact factor: 5.372

3.  Hyperphenylalaninemia in the hph-1 mouse mutant.

Authors:  J D McDonald; V C Bode
Journal:  Pediatr Res       Date:  1988-01       Impact factor: 3.756

4.  Phenylalanine hydroxylase from rat liver.

Authors:  S Kaufman
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

5.  Rat liver phenylalanine hydroxylase. Activation by sulfhydryl modification.

Authors:  M A Parniak; S Kaufman
Journal:  J Biol Chem       Date:  1981-07-10       Impact factor: 5.157

6.  Specific-locus test shows ethylnitrosourea to be the most potent mutagen in the mouse.

Authors:  W L Russell; E M Kelly; P R Hunsicker; J W Bangham; S C Maddux; E L Phipps
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

7.  Hyperphenylalaninemia due to dihydropteridine reductase deficiency: diagnosis by enzyme assays on dried blood spots.

Authors:  N Arai; K Narisawa; H Hayakawa; K Tada
Journal:  Pediatrics       Date:  1982-09       Impact factor: 7.124

8.  Studies on the molecular defect in phenylketonuria and hyperphenylalaninaemia using antibodies against phenylalanine hydroxylase.

Authors:  K Bartholomé; A Dresel
Journal:  J Inherit Metab Dis       Date:  1982       Impact factor: 4.982

9.  Selection for phenylalanine hydroxylase activity in cells transformed with recombinant retroviruses.

Authors:  F D Ledley; T Hahn; S L Woo
Journal:  Somat Cell Mol Genet       Date:  1987-03

10.  Retroviral-mediated gene transfer of human phenylalanine hydroxylase into NIH 3T3 and hepatoma cells.

Authors:  F D Ledley; H E Grenett; M McGinnis-Shelnutt; S L Woo
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

View more
  49 in total

Review 1.  Mouse chromosome 10.

Authors:  B A Taylor; W N Frankel; R H Reeves
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

Review 2.  Mouse chromosome 10.

Authors:  B A Taylor; M J Justice; R Reeves
Journal:  Mamm Genome       Date:  1991       Impact factor: 2.957

Review 3.  State-of-the-Art 2019 on Gene Therapy for Phenylketonuria.

Authors:  Hiu Man Grisch-Chan; Gerald Schwank; Cary O Harding; Beat Thöny
Journal:  Hum Gene Ther       Date:  2019-09-09       Impact factor: 5.695

4.  An Oak Ridge legacy: the specific locus test and its role in mouse mutagenesis.

Authors:  A P Davis; M J Justice
Journal:  Genetics       Date:  1998-01       Impact factor: 4.562

Review 5.  The role of the laboratory mouse in the human genome project.

Authors:  M H Meisler
Journal:  Am J Hum Genet       Date:  1996-10       Impact factor: 11.025

6.  Differential effects of low-phenylalanine protein sources on brain neurotransmitters and behavior in C57Bl/6-Pah(enu2) mice.

Authors:  Emily A Sawin; Sangita G Murali; Denise M Ney
Journal:  Mol Genet Metab       Date:  2014-02-08       Impact factor: 4.797

Review 7.  Mouse models of genetic disease: new approaches, new paradigms.

Authors:  S D Brown
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

Review 8.  Nutritional management of PKU with glycomacropeptide from cheese whey.

Authors:  D M Ney; S T Gleason; S C van Calcar; E L MacLeod; K L Nelson; M R Etzel; G M Rice; J A Wolff
Journal:  J Inherit Metab Dis       Date:  2008-10-29       Impact factor: 4.982

Review 9.  Gene Therapy for the Treatment of Neurological Disorders: Metabolic Disorders.

Authors:  Dominic J Gessler; Guangping Gao
Journal:  Methods Mol Biol       Date:  2016

10.  Myelin turnover in hyperphenylalaninaemia. A re-evaluation with the HPH-5 mouse.

Authors:  F A Hommes; L Moss
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.